Hydrocortisone directly promotes cholesterol accumulation in macrophages

Annals of the Rheumatic Diseases

Volumn 73, Issue 6, 2014, Pages 1274-1276

  Greco, Daniela ^a   Favari, Elda ^a   Adorni, Maria Pia ^a   Zimetti, Francesca ^a   Gatti, Rita ^a   Bernini, Franco ^a   Ronda, Nicoletta ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOID X RECEPTOR;

ACUTE MONOCYTIC LEUKEMIA; AUTOIMMUNE DISEASE; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DRUG RECEPTOR BINDING; FOAM CELL; HUMAN; LETTER; MACROPHAGE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ATHEROSCLEROSIS; AUTOIMMUNE DISEASES; CORTICOSTEROIDS; LIPIDS;

ANTI-INFLAMMATORY AGENTS; ATHEROSCLEROSIS; CELL LINE, TUMOR; CHOLESTEROL; CHOLESTEROL, LDL; FOAM CELLS; HUMANS; HYDROCORTISONE; MACROPHAGES;

EID: 84899936659     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204806     Document Type: Letter

References (10)

1. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004;141: 764-70.
2. Adorni MP, Zimetti F, Puntoni M, et al. Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis. J Lipid Res 2012;53: 984-9.
3. Favari E, Zimetti F, Bortnicka AE, et al. Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages. FEBS Lett 2005;579: 6537-42. (Pubitemid 41682436)
4. Zanotti I, Favari E, Bernini F. Cellular cholesterol efflux pathways: impact on intracellular lipid trafficking and methodological considerations. Curr Pharm Biotechnol 2012;13: 292-302.
5. Ronda N, Gatti R, Giacosa R, et al. Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway. Arthritis Rheum 2002;46: 1595-601. (Pubitemid 34620207)
6. Voloshyna I, Modanyil S, Littlefield MJ, et al. Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages. Exp Biol Med 2013;238: 1192-1197.
7. Ronda N, Favari E, Borghi MO, et al. Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 2014;73: 609-15.
8. Karp I, Abrahamowicz M, Fortin PR, et al. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum 2008;59: 169-75. (Pubitemid 351272950)
9. Amaya-Amaya J, Sarmiento-Monroy JC, Mantilla RD, et al. Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunol Res 2013;56: 267-86.
10. Condon MB, Ashby D, Pepper RJ, et al. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis 2013;72: 1280-6.